WT1 and type 1 diabetes mellitus: In addition, treatment of type 1 diabetes with a combination of resveratrol and human umbilical cord mesenchymal stem cells increased the number of podocytes and the expression of the podocyte-associated protein nephrin and Wilm’s tumor 1 (WT1), resulting in an amelioration of renal pathology [20].